HEXIM1 and carcinoma: RNA-seq analysis after 4 h of in vitro treatment, demonstrated that pathway modulation (HEXIM1) was strongly increased upon the combination of BI 894999 (10 nM) and CCS1477 (300 nM) vs mono-treatment in all four NUT carcinoma cell lines (Fig. 3c).